Your browser doesn't support javascript.
loading
A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activity.
Rakonjac Ryge, Marija; Tanabe, Michiharu; Provost, Patrick; Persson, Bengt; Chen, Xinsheng; Funk, Colin D; Rinaldo-Matthis, Agnes; Hofmann, Bettina; Steinhilber, Dieter; Watanabe, Takashi; Samuelsson, Bengt; Rådmark, Olof.
Afiliación
  • Rakonjac Ryge M; Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden.
  • Tanabe M; Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden; Department of Neurosurgery, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago 6838504, Japan.
  • Provost P; CHUQ Research Center/CHUL, 2705 Blvd Laurier, Quebec, QC G1V 4G2, Canada; Faculty of Medicine, Université Laval, Quebec, QC G1V 0A6, Canada.
  • Persson B; Science for Life Laboratory, Dept of Cell and Molecular Biology, Uppsala University, Box 596, S-75124 Uppsala, Sweden.
  • Chen X; Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Funk CD; Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Rinaldo-Matthis A; Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden.
  • Hofmann B; Institute of Pharmaceutical Chemistry/ZAFES, University of Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany.
  • Steinhilber D; Institute of Pharmaceutical Chemistry/ZAFES, University of Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany.
  • Watanabe T; Department of Neurosurgery, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago 6838504, Japan.
  • Samuelsson B; Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden.
  • Rådmark O; Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden. Electronic address: olof.radmark@ki.se.
Arch Biochem Biophys ; 545: 179-85, 2014 Mar 01.
Article en En | MEDLINE | ID: mdl-24480307
5-Lipoxygenase (5-LOX) catalyzes two steps in conversion of arachidonic acid to proinflammatory leukotrienes. Lipoxygenases, including human 5-LOX, consist of an N-terminal C2-like ß-sandwich and a catalytic domain. We expressed the 5-LOX domains separately, these were found to interact in the yeast two-hybrid system. The 5-LOX structure suggested association between Arg(101) in the ß-sandwich and Asp(166) in the catalytic domain, due to electrostatic interaction as well as hydrogen bonds. Indeed, mutagenic replacements of these residues led to loss of two-hybrid interaction. Interestingly, when Arg(101) was mutated to Asp in intact 5-LOX, enzyme activity was increased. Thus, higher initial velocity of the reaction (vinit) and increased final amount of products were monitored for 5-LOX-R101D, at several different assay conditions. In the 5-LOX crystal structure, helix α2 and adjacent loops (including Asp(166)) of the 5-LOX catalytic domain has been proposed to form a flexible lid controlling access to the active site, and lid movement would be determined by bonding of lid residues to the C2-like ß-sandwich. The more efficient catalysis following disruption of the R101-D166 ionic association supports the concept of such a flexible lid in human 5-LOX.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Araquidonato 5-Lipooxigenasa Límite: Humans Idioma: En Revista: Arch Biochem Biophys Año: 2014 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Araquidonato 5-Lipooxigenasa Límite: Humans Idioma: En Revista: Arch Biochem Biophys Año: 2014 Tipo del documento: Article País de afiliación: Suecia